Join
Live feed
·
PRReleasevia Quantisnow
Agile Therapeutics Inc. logo

Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024

ByQuantisnow·Wall Street's wire, on your screen.
AGRX· Agile Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGRX (Agile Therapeutics Inc.) and more on Quantisnow.